These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28890370)

  • 1. A mechanistic insight into protein-ligand interaction, folding, misfolding, aggregation and inhibition of protein aggregates: An overview.
    Chandel TI; Zaman M; Khan MV; Ali M; Rabbani G; Ishtikhar M; Khan RH
    Int J Biol Macromol; 2018 Jan; 106():1115-1129. PubMed ID: 28890370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Layers of structure and function in protein aggregation.
    Tanaka M; Komi Y
    Nat Chem Biol; 2015 Jun; 11(6):373-7. PubMed ID: 25978986
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploration of ligand-induced protein conformational alteration, aggregate formation, and its inhibition: A biophysical insight.
    Nusrat S; Khan RH
    Prep Biochem Biotechnol; 2018 Jan; 48(1):43-56. PubMed ID: 29106330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases.
    Eftekharzadeh B; Hyman BT; Wegmann S
    Mech Ageing Dev; 2016 Jun; 156():1-13. PubMed ID: 27005270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles-protein interaction: Role in protein aggregation and clinical implications.
    Parveen R; Shamsi TN; Fatima S
    Int J Biol Macromol; 2017 Jan; 94(Pt A):386-395. PubMed ID: 27746352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.
    Soto C; Pritzkow S
    Nat Neurosci; 2018 Oct; 21(10):1332-1340. PubMed ID: 30250260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation.
    Kushwah N; Jain V; Yadav D
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31941036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology.
    Yang H; Hu HY
    FEBS J; 2016 Oct; 283(20):3705-3717. PubMed ID: 27016044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein aggregates stimulate macropinocytosis facilitating their propagation.
    Yerbury JJ
    Prion; 2016 Mar; 10(2):119-26. PubMed ID: 26963158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein aggregation: A detrimental symptom or an adaptation mechanism?
    Lippi A; Krisko A
    J Neurochem; 2024 Aug; 168(8):1426-1441. PubMed ID: 37694504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies.
    Basha S; Mukunda DC; Rodrigues J; Gail D'Souza M; Gangadharan G; Pai AR; Mahato KK
    Ageing Res Rev; 2023 Sep; 90():102017. PubMed ID: 37468112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the energy landscapes for native folding and aggregation of PrP.
    Dee DR; Woodside MT
    Prion; 2016 May; 10(3):207-20. PubMed ID: 27191683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein aggregation and neurodegenerative diseases: From theory to therapy.
    Kumar V; Sami N; Kashav T; Islam A; Ahmad F; Hassan MI
    Eur J Med Chem; 2016 Nov; 124():1105-1120. PubMed ID: 27486076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling protein aggregation as an ageing related process or a neuropathological response.
    Trigo D; Nadais A; da Cruz E Silva OAB
    Ageing Res Rev; 2019 May; 51():67-77. PubMed ID: 30763619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting protein aggregation for the treatment of degenerative diseases.
    Eisele YS; Monteiro C; Fearns C; Encalada SE; Wiseman RL; Powers ET; Kelly JW
    Nat Rev Drug Discov; 2015 Nov; 14(11):759-80. PubMed ID: 26338154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein aggregation and ER stress.
    Ogen-Shtern N; Ben David T; Lederkremer GZ
    Brain Res; 2016 Oct; 1648(Pt B):658-666. PubMed ID: 27037184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperones biochemistry and role in neurodegenerative diseases.
    Chaari A
    Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misfolding and aggregation of nascent proteins: a novel mode of toxic cadmium action in vivo.
    Tamás MJ; Fauvet B; Christen P; Goloubinoff P
    Curr Genet; 2018 Feb; 64(1):177-181. PubMed ID: 28936749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.